KPV - 10MG [Tripeptide Anti-Inflammatory Research Compound]

Tripeptide Anti-Inflammatory Research Compound

KPV (10mg) is supplied in Australia with fast domestic shipping to all states and territories.

KPV is an endogenous three-amino-acid peptide derived from the C-terminus of α-melanocyte-stimulating hormone (α-MSH). Research interest centres on its targeted anti-inflammatory activity at mucosal and epidermal barriers without broad immune suppression — distinguishing it from corticosteroid and immunosuppressant mechanisms. KPV is studied in models of IBD, Crohn's disease, and ulcerative colitis, where reducing mucosal inflammation without blunt immunosuppression is a central research challenge.

The same anti-inflammatory mechanism is studied in epidermal wound healing, inflammatory skin condition models, and barrier function restoration.

Key Research Areas

• Mucosal Inflammation — Studied in IBD, Crohn's disease, and ulcerative colitis research models
• Intestinal Barrier Function — Studied for epithelial barrier repair and permeability models
• Epidermal Repair — Studied for wound healing and inflammatory skin condition models
• Targeted Immune Modulation — Anti-inflammatory activity without broad immunosuppression
• Antimicrobial Activity — In vitro activity against bacterial and fungal pathogens

Supplied as lyophilized powder, verified by HPLC and mass spectrometry. 10mg per vial. Fast domestic shipping across Australia.

⚠ For in-vitro research and laboratory use only. Not for human consumption.